VC-backed Repare Therapeutics goes public, raises $220m

Repare Therapeutics, a Boston- and Montreal-based precision oncology company, has raised about US$220 million for its IPO after pricing its 11 million shares at US$20 per share.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this